Silihan lan utang jangka dawa perusahaan HeartBeam Corporation (BEAT)

Serving as an assessment tool, the HeartBeam, Inc. (BEAT) price chart on GURU.Markets highlights confidence in the engineering team focused on implementing remote heart monitoring systems, where the indicator stands at 0.00. The business generates revenue through the sale of miniature ECG sensors and cloud-based AI analysis. Meanwhile, mass production and clinical trials have been delegated to external contractors, creating an outsourcing dependency despite strict patent protection.

Long-term debt measures the total credit obligations with a maturity of more than one year, allowing for an assessment of financial leverage stability and the development financing strategy. By analyzing the issuer's long-term liabilities, an investor identifies the resource base for scaling, which in the case of HeartBeam, Inc. (BEAT) provides for the hiring of highly qualified cardiologists and engineers to create advanced remote cardiac monitoring systems.